Jefferies Group upgraded shares of LyondellBasell (NYSE:LYB) from a hold rating to a buy rating in a report published on Wednesday, Marketbeat Ratings reports. The firm currently has $121.95 price target on the specialty chemicals company’s stock, up from their previous price target of $7
Oil driller ConocoPhillips (NYSE:COP) is benefiting from rising oil prices and rewarding investors with dividend hikes. However, the company's drilling-focused business hasn't been able to sustain a high dividend in the past, cutting the payment in 2016 amid low oil prices. This suggests that d
&l;p&g;&l;img class=&q;size-full wp-image-1343&q; src=&q;http://blogs-images.forbes.com/mikescott/files/2018/01/CSP.jpg?width=960&q; alt=&q;&q; data-height=&q;445&q; data-width=&q;1000&q;&g; The Masdar-backed Gemasolar concentrated solar power plant in Spain. A similar plant will be open in the UAE in the next few years.
Even in the Middle East, home to some of the world&a;rsquo;s largest....More>>>
Media stories about Conatus Pharmaceuticals (NASDAQ:CNAT) have trended somewhat positive recently, Accern Sentiment reports. The research firm scores the sentiment of press coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. Conatus Pharmaceuticals earned a coverage....More>>>
The title of this article may generate strong responses from some, who will reply: “never!” And indeed, if a value trap is defined as a stock that is not a value, then clearly a value trap is never a value. (There aren’t many rich dialetheists on Wall Street.) But let’s take a more nuanced view of a value trap and follow Investopedia.com in defining a value trap, which I....More>>>
Legendary investor Bill Miller is the former chairman and chief investment officer of Legg Mason Capital Management. He has been named fund manager of the decade by Morningstar and ranked as the top 30 most influential people in investing by SmartMoney. Below is an edited summary of his interview with The Investor’s Podcast where he talks about determining the intrinsic value of various....More>>>
Brokerages forecast that McDermott International (NYSE:MDR) will post $0.09 earnings per share for the current quarter, according to Zacks. Two analysts have made estimates for McDermott International’s earnings, with the lowest EPS estimate coming in at $0.07 and the highest estimate coming in at $0.11. McDermott International reported earnings of $0.13 per share in the same quarter last....More>>>
As we predicted earlier this week, Alibaba Group Holding Ltd. (NYSE: BABA) turned in a big showing in today’s “Singles’ Day” – smashing its sales record with ease and underscoring yet another reason we view this stock as a “must-own” wealth-builder.
Retailers using Alibaba’s e-commerce retail platforms saw merchandise....More>>>
Jeep celebrated its 75th anniversary in 2016. It’s one of the most Iconic American brands, and now owned by Fiat-Chrysler Automobiles, or FCA (NYSE:FCAU) for short. It’s almost as if the word “Jeep” has come to describe any terrain-worthy car that a civilian can buy.
Jeep also is one of the fastest-growing major auto brands with a significant U.S. presence. In 2016,....More>>>
Paypex (CURRENCY:PAYX) traded 1% lower against the dollar during the one day period ending at 16:00 PM Eastern on May 20th. In the last week, Paypex has traded 45.6% higher against the dollar. Paypex has a total market capitalization of $142.70 million and $8,938.00 worth of Paypex was traded
Yext (NYSE:YEXT) CFO Steven Cakebread sold 20,000 shares of the stock in a transaction that occurred on Thursday, May 17th. The stock was sold at an average price of $15.10, for a total transaction of $302,000.00. The transaction was disclosed in a document filed with the SEC, which is availabl
For many retired Americans, Social Security isn't just a check they receive each month. It's a financial lifeline that keeps them above the federal poverty line and allows them to make ends meet. An analysis from the Center on Budget and Policy Priorities in 2016 found that the mere existence of
Bruker (NASDAQ:BRKR) was upgraded by Zacks Investment Research from a “hold” rating to a “buy” rating in a report released on Friday. The brokerage presently has a $34.00 price target on the medical research company’s stock. Zacks Investment Research‘s target